Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-03-17 Purchase |
2023-03-17 5:03 pm |
Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO |
6,300 | $7.8623 | $49,532 | 12,800 (Direct) |
View |
2023-03-09 Purchase |
2023-03-09 5:56 pm |
Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO |
6,500 | $7.735 | $50,278 | 6,500 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-01-01 Tax Withholding |
2024-01-03 4:44 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO |
9,125 | $1.05 | 122,813 (Direct) |
View |
2024-01-01 Exercise |
2024-01-03 4:44 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO |
27,000 | $0 | 122,813 (Direct) |
View |
2023-08-01 Exercise |
2023-08-03 4:24 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO |
15,575 | $0 | 70,663 (Direct) |
View |
2023-08-01 Tax Withholding |
2023-08-03 4:24 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO |
4,437 | $9.81 | 70,663 (Direct) |
View |
2023-02-01 Option Award |
2023-02-03 5:04 pm |
N/A 2033-01-31 |
Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and CEO |
486,000 | $0 | 486,000 (Direct) |
View |
2022-08-01 Option Award |
2022-08-02 5:10 pm |
N/A 2032-07-31 |
Aclaris Therapeutics Inc. | ACRS | Manion Douglas J. Pres and COO |
280,100 | $0 | 280,100 (Direct) |
View |
2022-03-11 Other |
2022-03-11 4:12 pm |
N/A N/A |
ARENA PHARMACEUTICALS INC | ARNA | Manion Douglas J. EVP Research & Development |
36,462 | $0 | 36,462 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 5:02 pm |
N/A N/A |
ARENA PHARMACEUTICALS INC | ARNA | Manion Douglas J. EVP Research & Development |
21,462 | $0 | 36,462 (Direct) |
View |
2021-08-15 Option Award |
2021-08-17 08:30 am |
N/A 2028-08-15 |
ARENA PHARMACEUTICALS INC | ARNA | Manion Douglas J. EVP Research & Development |
120,200 | $0 | 120,200 (Direct) |
View |